- Home
- RENE vs GNFT Comparison
RENE vs GNFT Comparison
Compare RENE & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENE
- GNFT
- Stock Information
- Founded
- RENE 2021
- GNFT 1999
- Country
- RENE United States
- GNFT France
- Employees
- RENE N/A
- GNFT N/A
- Industry
- RENE Blank Checks
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RENE Finance
- GNFT Health Care
- Exchange
- RENE Nasdaq
- GNFT Nasdaq
- Market Cap
- RENE 243.8M
- GNFT 249.0M
- IPO Year
- RENE 2022
- GNFT 2019
- Fundamental
- Price
- RENE $11.50
- GNFT $6.10
- Analyst Decision
- RENE
- GNFT Strong Buy
- Analyst Count
- RENE 0
- GNFT 1
- Target Price
- RENE N/A
- GNFT $13.00
- AVG Volume (30 Days)
- RENE 42.3K
- GNFT 27.9K
- Earning Date
- RENE 01-01-0001
- GNFT 09-19-2024
- Dividend Yield
- RENE N/A
- GNFT N/A
- EPS Growth
- RENE N/A
- GNFT N/A
- EPS
- RENE 0.36
- GNFT 0.47
- Revenue
- RENE N/A
- GNFT $86,225,222.00
- Revenue This Year
- RENE N/A
- GNFT $155.44
- Revenue Next Year
- RENE N/A
- GNFT N/A
- P/E Ratio
- RENE $32.09
- GNFT $12.48
- Revenue Growth
- RENE N/A
- GNFT 175.45
- 52 Week Low
- RENE $10.84
- GNFT $2.97
- 52 Week High
- RENE $11.58
- GNFT $6.13
- Technical
- Relative Strength Index (RSI)
- RENE 85.94
- GNFT 70.40
- Support Level
- RENE $11.40
- GNFT $5.41
- Resistance Level
- RENE $11.51
- GNFT $5.84
- Average True Range (ATR)
- RENE 0.01
- GNFT 0.31
- MACD
- RENE 0.00
- GNFT 0.05
- Stochastic Oscillator
- RENE 83.33
- GNFT 97.19
About RENE Cartesian Growth Corporation II
Cartesian Growth Corp II is a blank check company.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.